1. Mechanical Complications of Acute Myocardial Infarction in the Reperfusion Era
Mechanical complications of acute myocardial infarction represent a paradox of modern cardiovascular medicine. Rapid diagnosis, primary percutaneous coronary intervention, antiplatelet therapy, anticoagulation, intensive care, and organized STEMI systems have dramatically reduced the frequency of catastrophic structural complications after myocardial infarction. Nevertheless, when ventricular septal rupture, papillary muscle rupture, or left ventricular free-wall rupture occurs, the clinical consequences remain severe and mortality remains substantial. Contemporary ESC data indicate that these complications now occur in fewer than 1% of acute myocardial infarctions, yet patients may present with major hemodynamic impairment requiring immediate intervention.
The three principal acute mechanical complications have different anatomical substrates and different physiological consequences. Papillary muscle rupture produces abrupt severe mitral regurgitation, often resulting in pulmonary edema and cardiogenic shock. Ventricular septal rupture creates a new left-to-right shunt, generating acute right ventricular volume and pressure overload while simultaneously reducing effective systemic cardiac output. Free-wall rupture allows blood to escape from the ventricular cavity into the pericardial space and can cause acute tamponade, electromechanical dissociation, or sudden death.
These complications share several management principles but should not be treated identically. All require rapid recognition, immediate imaging, hemodynamic stabilization, and involvement of a multidisciplinary team. The 2025 AATS expert consensus specifically addresses surgical management of AMI complications, including cardiogenic shock, papillary muscle rupture, post-infarction ventricular septal defect, free-wall rupture, and mechanical circulatory support.
A critical feature is that the infarcted myocardium is structurally weak. Conventional sutures may tear through necrotic tissue, and repair performed too early may therefore be technically difficult. At the same time, excessive delay can allow progressive hemodynamic deterioration, organ failure, enlargement of the rupture, or recurrent rupture. Consequently, timing is individualized according to the complication, anatomical morphology, shock severity, and response to stabilization.
The contemporary treatment environment is also changing. Surgical repair remains fundamental, but transcatheter approaches have expanded considerably. Percutaneous closure of selected post-infarction VSDs and transcatheter edge-to-edge mitral repair in selected papillary muscle rupture patients may provide options for individuals with prohibitive surgical risk. These approaches should not be interpreted as replacements for surgery in all patients. Rather, they represent additional tools within a Heart-Team strategy.
Temporary mechanical circulatory support has also become increasingly relevant. It can stabilize selected patients with severe cardiogenic shock and provide a bridge to definitive surgery or transcatheter intervention. However, mechanical support does not repair the anatomical defect and may sometimes alter loading conditions in ways that worsen the shunt or complicate management. The device must therefore be selected according to the specific mechanical lesion.
The central message is that these patients are not simply “post-MI shock” patients. Their shock has an anatomical cause. Pharmacological therapy alone cannot correct a ruptured papillary muscle, septum, or ventricular wall. Definitive management requires identification and treatment of the structural lesion while simultaneously protecting the patient from irreversible secondary organ injury.
2. Pathobiology and Timing of Post-Infarction Mechanical Failure
Mechanical complications generally occur when myocardial necrosis progresses beyond a threshold at which the structural integrity of the ventricular wall, interventricular septum, or papillary apparatus can no longer withstand intracardiac pressure and wall stress. The timing is influenced by infarct size, location, reperfusion, collateral circulation, ventricular loading, and individual myocardial susceptibility.
Historically, mechanical complications were more common during the early days following transmural infarction. Contemporary reperfusion has altered both their incidence and clinical presentation. Nevertheless, patients with delayed reperfusion or unsuccessful reperfusion remain vulnerable because prolonged ischemia produces extensive necrosis. The mechanical event may occur after a period of apparent stability, making continued vigilance important.
The infarcted myocardium undergoes progressive structural changes. Necrotic cardiomyocytes lose contractile integrity, inflammatory cells infiltrate the damaged tissue, and extracellular matrix degradation weakens the infarct zone. During subsequent healing, collagen deposition gradually restores structural strength. The interval between necrosis and mature scar therefore represents a period of particular vulnerability.
Papillary muscle rupture has a distinctive anatomical pattern. The posteromedial papillary muscle is more frequently involved because it commonly has a single dominant blood supply, whereas the anterolateral papillary muscle usually receives dual arterial supply. Acute rupture can therefore occur in the setting of an inferior or posterior infarction and can produce catastrophic mitral regurgitation.
Ventricular septal rupture generally occurs within the infarcted septal territory. The resulting defect may be relatively discrete or highly complex, with friable necrotic margins and serpiginous channels extending through the septum. Inferior infarctions may produce particularly challenging posterior or basal defects.
Free-wall rupture can be complete or contained. Complete rupture causes communication between the left ventricular cavity and pericardial space and may result in immediate tamponade and death. A contained rupture can produce a pseudoaneurysm, in which blood is confined by pericardium or scar tissue rather than by normal myocardial wall. The distinction is clinically important because pseudoaneurysms may remain stable temporarily but carry a risk of subsequent rupture.
The modern understanding of mechanical complications therefore emphasizes a dynamic process rather than a single anatomical event. The defect can evolve rapidly. A small VSD may enlarge. A partially ruptured papillary muscle may progress to complete disruption. A contained free-wall rupture may become unstable.
This dynamic behavior explains why repeated echocardiographic evaluation can be necessary even after the initial diagnosis. The 2026 ESC consensus emphasizes that recurrence or progression of post-AMI mechanical complications can have major consequences and that careful monitoring is required during hospitalization and after repair.
The timing of intervention consequently represents a balance between two competing biological realities: unstable necrotic tissue may be difficult to repair, but untreated mechanical failure may be rapidly fatal. This tension is particularly important in VSR, where some patients may be temporarily stabilized before repair, while others require immediate intervention because of refractory shock.
3. Risk Factors for Mechanical Complications After Myocardial Infarction
Although mechanical complications are now rare, they do not occur randomly. Certain clinical and anatomical factors increase risk. Large transmural infarction, delayed reperfusion, older age, hypertension, female sex, first myocardial infarction without protective ventricular remodeling, poor collateral circulation, and extensive myocardial necrosis have historically been associated with increased risk.
Delayed diagnosis remains particularly important. Patients who present late after symptom onset may have a larger infarct burden and more extensive myocardial necrosis. In regions where access to primary PCI is delayed, mechanical complications remain clinically important despite improvements in other areas of cardiovascular care.
Advanced age is another major risk factor. Older patients frequently have reduced myocardial reserve, more comorbid disease, and increased frailty. They may also tolerate acute hemodynamic changes poorly. Contemporary surgical series consistently identify advanced age as a predictor of adverse outcome.
Hypertension may contribute through increased ventricular wall stress. According to the Law of Laplace, wall tension rises with ventricular pressure and radius and decreases with wall thickness. An infarcted ventricular wall therefore becomes particularly vulnerable when exposed to high intracavitary pressure.
Female sex has historically been associated with increased risk in several studies, although the mechanism is likely multifactorial. Women may present at older ages, have different coronary anatomy and comorbidity profiles, and experience delays in recognition or reperfusion in some clinical settings.
Poor nutritional status and frailty have also emerged as important markers of vulnerability. A Japanese cohort of patients with AMI-associated mechanical complications found associations with age, poor nutritional status, higher Killip class, delayed MI diagnosis, elevated lactate, impaired TIMI flow, and single-vessel disease. Thirty-day mortality among patients with mechanical complications was 60% in that cohort.
The clinical context of the infarction matters as well. A patient with a large anterior STEMI and persistent occlusion may develop extensive septal necrosis. A patient with an inferior infarction involving the posterior papillary muscle may be at risk for acute severe mitral regurgitation. A large lateral or posterior infarction may produce free-wall rupture.
Reperfusion changes risk but does not eliminate it. Primary PCI can limit infarct size and preserve myocardial integrity, but mechanical complications can still occur when reperfusion is delayed, incomplete, or unsuccessful.
A particularly important concept is that mechanical complications may occur despite apparently successful coronary reperfusion. Reopening the infarct-related artery does not immediately restore structural integrity to already necrotic myocardium. The patient remains vulnerable during the healing period.
Risk assessment should therefore continue after successful PCI. Sudden new hypotension, a new murmur, acute pulmonary edema, rising lactate, unexplained right-sided volume overload, recurrent chest pain, or electromechanical instability should prompt immediate consideration of a mechanical complication.
The practical lesson is that risk factors should increase vigilance rather than serve as exclusion criteria. A patient without classic risk factors can still develop rupture, while a high-risk patient may never experience a mechanical event. Clinical deterioration remains the decisive signal.
4. Clinical Recognition of Sudden Mechanical Deterioration
The clinical presentation of mechanical complications is often dominated by sudden hemodynamic deterioration. Unfortunately, the symptoms may overlap with severe myocardial infarction, acute left ventricular failure, right ventricular infarction, arrhythmia, or recurrent ischemia. The clinician must therefore recognize patterns that suggest an anatomical complication.
Papillary muscle rupture commonly produces abrupt severe mitral regurgitation. The patient may develop sudden pulmonary edema, severe dyspnea, hypotension, tachycardia, and a new systolic murmur. However, the murmur may be less prominent than expected because severely reduced forward stroke volume can reduce the audible regurgitant jet.
Ventricular septal rupture often produces a new harsh holosystolic murmur accompanied by a palpable thrill, although this classic finding may not always be present. The patient may develop rapidly worsening heart failure, hypotension, elevated jugular venous pressure, and signs of systemic hypoperfusion. The key physiological event is the sudden left-to-right shunt.
Free-wall rupture may present dramatically with sudden hypotension, pulseless electrical activity, syncope, or cardiac arrest. A patient may deteriorate within minutes because blood rapidly accumulates in the pericardial space. Alternatively, a contained rupture may produce a more gradual course, sometimes with persistent chest discomfort, hypotension, or an abnormal pericardial effusion.
The differential diagnosis is broad. Acute ventricular dysfunction after MI can result from extensive ischemia without rupture. Papillary muscle dysfunction may produce severe mitral regurgitation without complete rupture. Right ventricular infarction can cause hypotension without a septal defect. Acute ventricular tachyarrhythmia can also produce sudden shock.
Therefore, echocardiography becomes central to rapid diagnosis. Bedside transthoracic echocardiography can rapidly detect a new VSD, severe mitral regurgitation, pericardial effusion, tamponade physiology, or abnormal ventricular anatomy. Transesophageal echocardiography can provide higher-resolution assessment when transthoracic windows are inadequate.
Laboratory findings can support severity assessment but are nonspecific. Rising lactate indicates tissue hypoperfusion. Renal dysfunction may reflect shock. Liver injury can develop rapidly in severe low-output states. These abnormalities are prognostically important because they indicate that the mechanical event is already producing systemic consequences.
The timing of deterioration relative to the infarction is also informative. A patient who becomes acutely unstable days after MI should trigger immediate consideration of rupture, even if the initial infarction was treated successfully.
Contemporary AHA and ESC documents emphasize prompt diagnostic evaluation and multidisciplinary management because these complications are uncommon enough that individual clinicians may encounter them infrequently.
The most important clinical principle is therefore diagnostic speed. Mechanical complications are time-critical anatomical emergencies. Waiting for a complete laboratory evaluation or relying on clinical examination alone can be dangerous. Immediate bedside imaging is usually the shortest route to identifying the problem.
5. Multimodality Imaging and the Emergency Diagnostic Pathway
Echocardiography is the cornerstone of diagnosis because it can be performed immediately and provides direct information about cardiac structure and hemodynamics. Transthoracic echocardiography is generally the first test, while transesophageal echocardiography is invaluable when image quality is limited or detailed anatomical characterization is required.
In papillary muscle rupture, echocardiography can identify flail mitral valve leaflets, ruptured papillary muscle heads, severe eccentric mitral regurgitation, left atrial pressure elevation, pulmonary hypertension, and secondary right ventricular effects. Three-dimensional transesophageal echocardiography may be particularly useful for defining leaflet pathology and planning surgical or transcatheter intervention.
For ventricular septal rupture, color Doppler can demonstrate abnormal left-to-right flow across the interventricular septum. The location, size, number of defects, and relation to valves and infarcted myocardium must be established. Complex defects may have multiple channels and irregular margins, making surgical planning dependent on detailed imaging.
Free-wall rupture is more challenging. Echocardiography can demonstrate pericardial effusion, tamponade physiology, regional myocardial discontinuity, intrapericardial clot, or pseudoaneurysm. In an unstable patient, bedside echocardiography should not be delayed for advanced imaging.
Computed tomography can provide detailed anatomical information in hemodynamically stable patients. It may help characterize pseudoaneurysm, ventricular anatomy, coronary anatomy, pericardial blood, and extracardiac structures. CT is especially useful when surgical planning requires a comprehensive anatomical map.
Cardiac magnetic resonance has an important role in selected stable patients but is rarely the first-line diagnostic modality during acute shock because it is time-consuming and requires patient stability.
Coronary angiography remains essential for defining coronary anatomy and planning revascularization. However, the angiographic procedure must be coordinated with stabilization and mechanical complication management. The patient should not be exposed to unnecessary delays when an immediately life-threatening rupture is evident.
Invasive hemodynamics can be particularly informative in VSR. Oxygen saturation measurements may demonstrate a step-up in right ventricular or pulmonary arterial oxygen saturation, supporting a left-to-right shunt. Right-sided pressures may be elevated, and cardiac output may be reduced.
Imaging should therefore answer three questions simultaneously:
What has ruptured?
How large and anatomically complex is the lesion?
What is the physiological consequence?
The third question is often overlooked. Anatomical size alone does not determine urgency. A relatively small VSD can produce severe shock in a patient with limited ventricular reserve, while a contained rupture may initially appear stable.
The 2026 ESC consensus specifically emphasizes urgent diagnostic evaluation and integration of modern imaging with multidisciplinary treatment planning.
The optimal diagnostic pathway is therefore rapid rather than exhaustive. In unstable patients, echocardiography should establish the diagnosis and guide immediate management. Additional imaging should be obtained only when it changes treatment planning and can be performed without unacceptable delay.
6. Papillary Muscle Rupture and Acute Ischemic Mitral Regurgitation
Papillary muscle rupture is one of the most dramatic mechanical complications of AMI because it transforms a localized infarction into abrupt severe mitral regurgitation. The left ventricle suddenly ejects a large proportion of its stroke volume backward into the left atrium, causing acute elevation of left atrial and pulmonary venous pressures.
The posteromedial papillary muscle is particularly vulnerable because it usually has a more limited arterial supply. Inferior or posterior myocardial infarction can therefore produce rupture of the posteromedial muscle. The anterolateral papillary muscle has dual blood supply and is less commonly ruptured.
The clinical presentation can be catastrophic. Pulmonary edema may develop rapidly. The patient may become hypotensive because effective forward stroke volume falls despite apparently vigorous ventricular contraction. Cardiogenic shock can occur rapidly.
One diagnostic challenge is that the classic murmur may be absent or relatively soft. Acute severe mitral regurgitation does not necessarily produce the same audible murmur as chronic mitral regurgitation because the left atrium has not had time to remodel and the pressure gradient between the ventricle and atrium may change rapidly.
Echocardiography is essential. It can demonstrate the flail leaflet, ruptured papillary muscle, severe regurgitant jet, and secondary pulmonary hypertension. Transesophageal echocardiography is often particularly valuable for surgical planning.
Medical therapy can stabilize selected patients temporarily. Vasodilators may reduce afterload when blood pressure permits, potentially increasing forward flow. Diuretics can reduce pulmonary congestion. Inotropes may support cardiac output when necessary. However, medical therapy cannot correct the structural rupture.
Mechanical support may be used in selected patients as a bridge to surgery. The choice of device requires careful consideration because the objective is to reduce the severity of hemodynamic collapse while avoiding worsening pulmonary congestion or other complications.
Urgent surgical intervention remains central for operable patients. The 2025 AATS consensus specifically includes papillary muscle rupture among AMI complications for which prompt definitive management should be considered.
The surgical strategy may involve mitral valve replacement or, in selected anatomical circumstances, repair. Because the papillary apparatus is infarcted and structurally fragile, replacement has traditionally been favored in complete rupture. Repair may be possible in partial rupture or selected anatomical patterns but requires careful assessment of tissue viability and valve geometry.
The decision to add coronary revascularization is individualized. Contemporary evidence does not establish a universal benefit for concomitant CABG in every emergency mechanical complication. The coronary anatomy, residual ischemia, target-vessel quality, operative risk, and overall clinical condition must be considered.
7. Contemporary Surgical Management of Papillary Muscle Rupture
Surgical treatment of papillary muscle rupture is directed toward eliminating acute severe mitral regurgitation while simultaneously addressing the ischemic substrate. Because the patient is often unstable, operative preparation must proceed rapidly.
Mitral valve replacement is frequently selected because complete papillary muscle rupture produces severe structural disruption. A durable prosthesis restores competent valve function without relying on infarcted papillary tissue. The choice between mechanical and biological prostheses depends on age, bleeding risk, anticoagulation considerations, comorbidities, and expected longevity.
Repair can be considered when the rupture is partial and adequate viable tissue remains. Techniques may include reattachment of the papillary muscle, neochordal reconstruction, annuloplasty, or combinations of these approaches. However, repair durability can be uncertain when the underlying myocardial tissue is ischemic and fragile.
The surgical field can be challenging because the infarcted myocardium is vulnerable to further tearing. Exposure must provide adequate visualization while minimizing unnecessary manipulation. If concomitant coronary bypass is performed, the surgeon must balance complete revascularization against operative time and physiological instability.
Preoperative imaging is therefore crucial. Three-dimensional transesophageal echocardiography can help define leaflet prolapse, papillary muscle anatomy, chordal disruption, and ventricular function. This information allows the surgical team to anticipate whether repair is realistic.
The patient’s hemodynamic state influences urgency. A patient in refractory pulmonary edema or cardiogenic shock generally cannot undergo prolonged stabilization while waiting for myocardial healing. Immediate or urgent intervention may be required.
Conversely, if a patient can be stabilized temporarily with medical therapy or mechanical support, a brief period may allow improved organ perfusion and surgical planning. However, prolonged delay without a compelling reason can be dangerous because severe mitral regurgitation remains an active mechanical lesion.
The postoperative period is dominated by ventricular recovery and right ventricular performance. Once severe mitral regurgitation is eliminated, the left ventricle experiences a sudden increase in effective afterload because it can no longer eject into the low-pressure left atrium. A ventricle that appeared hyperdynamic before surgery may therefore develop postoperative dysfunction.
Pulmonary hypertension may also persist temporarily. The right ventricle may be compromised by the combination of infarction, elevated pulmonary vascular resistance, and postoperative loading changes.
Contemporary surgical series demonstrate that early mortality remains substantial, but survivors can have meaningful long-term outcomes. A multicenter Caution study reported 37.4% in-hospital mortality across surgically treated post-AMI mechanical complications; among hospital survivors, long-term survival was substantially better.
The key surgical lesson is that the operation should not be judged solely by technical valve competence. Successful treatment requires restoration of an acceptable systemic circulation, management of the infarcted ventricle, and prevention of postoperative low-output syndrome.
8. Transcatheter Mitral Intervention in Papillary Muscle Rupture
Transcatheter treatment has expanded the therapeutic options for patients with acute ischemic mitral regurgitation, particularly those considered extremely high risk for open surgery. Transcatheter edge-to-edge repair may approximate the mitral leaflets and reduce regurgitant volume without requiring sternotomy or cardiopulmonary bypass.
However, papillary muscle rupture presents a special anatomical challenge. The mechanism is not simply leaflet malcoaptation caused by chronic ventricular remodeling. There may be complete disruption of the subvalvular apparatus, flail leaflet segments, severe tissue fragility, and rapidly changing ventricular geometry.
Patient selection is therefore critical. Transcatheter repair may be considered when anatomy is suitable and surgical risk is prohibitive or exceptionally high. The procedure should not be interpreted as a universal replacement for urgent surgery.
The first requirement is adequate leaflet tissue for grasping. Severe flail motion, extensive tissue destruction, or unfavorable leaflet anatomy may make edge-to-edge repair impossible. Three-dimensional transesophageal echocardiography is central to determining feasibility.
The second issue is hemodynamic stability. A patient in profound shock may require temporary circulatory support before the transcatheter procedure. Mechanical support can provide a window during which the valve intervention is planned.
The third issue is durability. Acute reduction in regurgitation can be life-saving, but long-term durability data for papillary muscle rupture are much less extensive than those available for chronic degenerative or functional mitral regurgitation.
The contemporary ESC consensus recognizes transcatheter approaches as increasingly relevant alternatives, particularly for high-risk or inoperable patients.
A Heart-Team decision is therefore essential. Surgical repair or replacement remains preferred when the patient is an acceptable operative candidate and the anatomy favors surgery. Transcatheter intervention becomes particularly attractive when surgical mortality is prohibitive and anatomy permits effective device deployment.
Another potential role is rescue therapy. If a patient is initially considered too unstable for surgery, successful transcatheter reduction of mitral regurgitation may restore enough hemodynamic stability to permit recovery and subsequent definitive management.
This evolving field illustrates a broader principle in mechanical AMI complications: treatment should be matched to anatomy and physiology rather than dictated by a single procedural philosophy. Surgery, transcatheter therapy, and mechanical support can be complementary rather than mutually exclusive.
9. Ventricular Septal Rupture After Myocardial Infarction
Post-infarction ventricular septal rupture creates an abnormal communication between the left and right ventricles. The resulting left-to-right shunt can cause sudden right ventricular volume overload, increased pulmonary blood flow, pulmonary hypertension, and a reduction in effective systemic cardiac output.
VSR commonly occurs several days after myocardial infarction but can present earlier or later depending on reperfusion and infarct evolution. The defect may be located in the anterior septum after an anterior infarction or in the posterior/basal septum after an inferior infarction.
The anatomy can be deceptively complex. Infarcted tissue may contain a serpiginous tunnel rather than a simple circular hole. The defect can enlarge rapidly because of continued mechanical stress on necrotic tissue.
Clinical presentation ranges from relatively compensated heart failure to profound cardiogenic shock. A new systolic murmur and thrill may suggest the diagnosis, but absence of these findings does not exclude it.
Echocardiography is the primary diagnostic tool. Color Doppler can demonstrate the shunt, while ventricular function and pulmonary pressures can be assessed simultaneously. Transesophageal echocardiography may be needed when transthoracic imaging is insufficient.
Right-heart catheterization can demonstrate an oxygen saturation step-up caused by the left-to-right shunt. Hemodynamic assessment can be particularly useful in complex cases and during planning for mechanical support.
The pathophysiology of VSR differs from that of primary pump failure. The left ventricle may eject a substantial volume into the low-pressure right ventricle rather than into the systemic circulation. Thus, systemic cardiac output can collapse even if total ventricular stroke volume remains relatively high.
The right ventricle becomes acutely overloaded. Pulmonary blood flow rises, pulmonary venous pressure increases, and pulmonary edema may develop. Eventually, the right ventricle can fail.
Surgical repair remains the principal definitive treatment for most significant VSRs. However, the optimal timing remains controversial because the infarcted septal tissue is friable and difficult to hold sutures during the early phase.
The contemporary ESC consensus and 2025 AATS document both recognize VSR as a complex emergency requiring individualized multidisciplinary decision-making.
The modern approach therefore avoids an oversimplified rule such as “operate immediately” or “always delay.” The correct strategy depends on defect anatomy, shock severity, tissue quality, response to stabilization, and availability of transcatheter or mechanical support.
10. Hemodynamic Consequences and Shock Physiology of Ventricular Septal Rupture
The defining physiological abnormality in VSR is the sudden creation of a left-to-right shunt. The magnitude of the shunt depends on defect size, systemic vascular resistance, pulmonary vascular resistance, ventricular pressures, and ventricular function.
Initially, blood moves from the high-pressure left ventricle into the right ventricle. This increases right ventricular volume and pulmonary blood flow. If pulmonary vascular resistance is low, the right ventricle may transmit substantial flow into the pulmonary circulation.
The increased pulmonary flow elevates left atrial return and can worsen pulmonary edema. At the same time, effective systemic forward flow falls because part of the left ventricular output is diverted into the pulmonary circulation.
As systemic blood pressure decreases, sympathetic activation increases vascular resistance and heart rate. Increased systemic vascular resistance can paradoxically worsen the left-to-right shunt because the pressure gradient between the left and right ventricles increases.
This explains why afterload manipulation is important. Reducing systemic vascular resistance can decrease the magnitude of the shunt and potentially improve effective systemic output when blood pressure permits. However, excessive vasodilation in a patient with profound shock may worsen systemic perfusion.
Inotropic therapy can increase contractility but may also increase myocardial oxygen demand and systemic pressure. Its use therefore requires careful balancing.
Mechanical support is particularly complicated. Devices that increase left ventricular unloading may reduce left-to-right shunting under certain conditions, but the physiological response depends on the device and configuration. Conversely, support strategies that increase systemic flow without addressing the defect can produce unexpected changes in shunt dynamics.
This is why device selection cannot be separated from the anatomy of the VSR. A mechanical support device should be considered only after understanding how it will affect left ventricular pressure, right ventricular loading, pulmonary blood flow, and systemic perfusion.
The severity of shock should also guide timing. Patients with refractory hypotension, rising lactate, renal injury, altered mental status, or escalating vasoactive requirements have a narrow therapeutic window.
A key clinical principle is that the VSR itself must eventually be closed. Medical therapy and mechanical support are bridges rather than definitive repairs in most cases.
11. Surgical Repair of Post-Infarction Ventricular Septal Rupture
Surgical repair of post-infarction VSR is technically demanding because the surgeon must close a defect in necrotic and friable myocardium without creating additional ventricular dysfunction. The exact technique depends on the location, size, tissue quality, and ventricular geometry.
Two broad strategies are commonly discussed: direct closure and patch repair. Direct closure may be possible for selected small defects with adequate tissue, but patch repair is frequently favored because sutures placed directly into necrotic myocardium can tear.
The infarct-exclusion concept aims to exclude the infarcted septal region from high-pressure ventricular flow by securing a patch to healthier tissue. The objective is to reduce tension on fragile myocardium and minimize recurrent rupture.
Surgical access depends on the defect location and ventricular anatomy. An infarctectomy or extensive debridement is generally avoided when possible because removing tissue can enlarge the defect and further compromise ventricular geometry. Instead, the surgeon seeks viable tissue capable of supporting the repair.
Concomitant CABG may be performed when coronary anatomy and clinical status justify revascularization. However, the decision is individualized because adding bypass can increase operative complexity and duration. Current guidelines acknowledge the limited randomized evidence regarding the incremental benefit of CABG in emergency mechanical complication surgery.
The major postoperative complication is residual or recurrent VSD. Even a small residual shunt can be clinically significant in a patient with impaired ventricular function. Echocardiographic surveillance is therefore essential.
Other complications include low cardiac output syndrome, bleeding, renal failure, arrhythmias, and multiorgan dysfunction.
Long-term data remain limited because the condition is rare. A systematic review identified only a modest number of studies with long-term follow-up and emphasized the predominance of retrospective cohorts and single-center series.
The Caution multicenter cohort provides contemporary perspective: overall in-hospital mortality after surgical treatment of post-AMI mechanical complications was 37.4%, while survivors demonstrated substantially better longer-term survival.
These figures illustrate an important point: the highest-risk period is the acute phase. Successful stabilization and definitive repair can fundamentally alter the subsequent prognosis.
12. Timing of Surgery: Immediate Repair Versus Delayed Stabilization
The timing of VSR surgery remains one of the most debated issues in contemporary management. The theoretical advantage of delaying surgery is biological: infarcted tissue may undergo fibrosis and become stronger, providing a more secure substrate for patch fixation.
The disadvantage is equally obvious. The patient remains exposed to a large intracardiac shunt, progressive heart failure, pulmonary edema, renal dysfunction, and cardiogenic shock.
Patients with refractory shock generally cannot tolerate prolonged waiting. For these patients, urgent repair or intervention may be necessary regardless of tissue quality.
Patients who are hemodynamically stable or can be stabilized with intensive medical therapy and temporary mechanical support may sometimes undergo delayed repair. The delay should be purposeful rather than arbitrary.
Mechanical support can potentially provide this bridge. By reducing ventricular loading and maintaining systemic perfusion, it may allow time for tissue stabilization and organ recovery. However, evidence remains limited, and device selection must account for shunt physiology.
The 2026 ESC consensus emphasizes that management should be individualized and increasingly incorporates temporary mechanical circulatory support as a bridge-to-procedure or bridge-to-recovery strategy in selected patients.
This represents an important evolution from the historical binary choice between immediate surgery and conservative treatment. Modern care can involve stabilization, imaging reassessment, temporary support, and definitive repair once the patient’s physiological condition and anatomy are optimized.
Nevertheless, delay should not become a reflex. A patient whose lactate is rising, vasopressor requirements are increasing, and organ function is deteriorating is not necessarily becoming a better surgical candidate with time.
The ideal approach is therefore physiology-driven timing. The patient should be reassessed repeatedly, and the decision should be based on whether stabilization is actually being achieved.
13. Transcatheter Closure of Post-Infarction Ventricular Septal Rupture
Transcatheter closure has emerged as an alternative for selected VSR patients who are at high or prohibitive surgical risk. Devices designed for septal defect closure can sometimes be deployed across the post-infarction defect, reducing or eliminating the left-to-right shunt.
The procedure is technically challenging because the defect margins may be friable and irregular. Device anchoring in necrotic tissue can lead to embolization, residual shunting, hemolysis, or recurrent rupture.
Timing also matters. Early after infarction, tissue may be extremely fragile. Later, fibrosis can provide stronger anchoring but the patient may already have developed severe organ dysfunction.
Imaging guidance is central. Transesophageal echocardiography, fluoroscopy, and sometimes CT reconstruction can define the defect and guide device selection.
Transcatheter closure can be particularly attractive in patients who have already undergone surgery or who have prohibitive operative risk. It may also be considered for residual VSD after surgical repair.
However, surgery remains the standard definitive strategy for many patients because surgical repair permits direct visualization and treatment of complex anatomy. The choice depends on defect location, size, tissue quality, patient stability, surgical risk, and institutional expertise.
The 2025 ESC consensus document specifically addresses VSR diagnosis and management, reflecting the increasing role of multidisciplinary and transcatheter strategies.
Transcatheter therapy should therefore be understood as an expanding option rather than a universally preferred intervention. In experienced centers, it can provide an important rescue pathway for patients who might otherwise have no acceptable therapeutic option.
14. Left Ventricular Free-Wall Rupture and Cardiac Tamponade
Left ventricular free-wall rupture is among the most catastrophic complications of AMI. Complete rupture allows blood to escape directly into the pericardial space, producing hemopericardium and potentially immediate cardiac tamponade.
The clinical presentation may be sudden death, electromechanical dissociation, profound hypotension, syncope, or rapid deterioration. Because there may be almost no time between rupture and circulatory collapse, diagnosis often occurs during emergency echocardiography or even at resuscitation.
Contained rupture creates a different phenotype. The rupture may be temporarily sealed by thrombus or pericardium, producing a pseudoaneurysm. The patient may remain relatively stable and can sometimes undergo detailed imaging before definitive repair.
The distinction between pseudoaneurysm and true ventricular aneurysm is critical. A true aneurysm contains all layers of the ventricular wall, whereas a pseudoaneurysm lacks normal myocardial wall and is contained by pericardium or scar tissue. The latter has a greater concern for rupture.
Echocardiography can rapidly demonstrate pericardial effusion, tamponade, or pseudoaneurysm. CT and MRI can provide more detailed anatomical characterization in stable patients.
Emergency treatment of free-wall rupture generally involves surgical repair. The goal is to control hemorrhage and restore ventricular integrity while minimizing additional injury to fragile myocardium.
Sutureless or patch-based techniques may be selected according to anatomy. The surgeon must avoid excessive tension because infarcted tissue can tear easily.
A 30-year single-center series of surgical repair for post-MI LV free-wall rupture reported 28.6% in-hospital mortality, with age over 75 years, preoperative cardiac arrest, and concurrent VSR independently associated with early death. Among survivors, longer-term survival was substantially better, with 3-year and 12-year survival rates of 82.5% and 55.2%, respectively.
These data illustrate that successful emergency rescue can provide meaningful long-term survival despite extremely high initial risk.
15. Surgical Techniques for Free-Wall Rupture and Left Ventricular Pseudoaneurysm
Surgical repair of free-wall rupture must accomplish two competing goals: control bleeding and preserve ventricular geometry. Aggressive debridement may remove the only tissue capable of supporting the repair and should therefore be carefully considered.
Patch repair is frequently used when the defect is large or the surrounding myocardium is friable. Biological or synthetic material can distribute tension over a larger surface area rather than concentrating stress at individual sutures.
Sutureless techniques can be useful in selected rupture patterns, particularly when the tissue is extremely fragile. These approaches may use patches and biological adhesives to seal the rupture without placing multiple deep sutures through necrotic myocardium.
The choice of technique is highly dependent on anatomy and surgeon experience. There is no single repair method that is appropriate for every rupture.
Pseudoaneurysm repair is generally performed electively when the patient can be stabilized because the contained rupture remains vulnerable to subsequent rupture. Surgical resection of the pseudoaneurysm and reconstruction of the ventricular wall may be performed.
Concomitant coronary revascularization can be considered according to coronary anatomy. However, as with other mechanical complications, the evidence supporting routine CABG in every case is limited.
The 2024 JACC focus review emphasizes that multimodality imaging and emerging transcatheter approaches have expanded management options for post-MI free-wall rupture and pseudoaneurysm.
Transcatheter closure of pseudoaneurysm has been reported in selected high-risk patients, but anatomy must be highly suitable. Large defects, unstable pseudoaneurysms, or proximity to critical structures may make surgical repair preferable.
Postoperative imaging is essential because recurrent or residual defects can occur. The 2026 ESC consensus emphasizes the importance of monitoring for recurrence even after apparently successful treatment.
16. Mechanical Circulatory Support in Post-Infarction Mechanical Complications
Mechanical circulatory support has become an increasingly important component of the treatment pathway for selected patients with AMI-associated mechanical complications and cardiogenic shock. Its purpose is not to replace definitive repair but to stabilize the circulation before, during, or after intervention.
VA-ECMO can provide rapid systemic circulatory support and oxygenation. It may be useful in profound cardiogenic shock or cardiac arrest, but it can increase left ventricular afterload and may worsen pulmonary congestion unless ventricular unloading is addressed.
Impella and other transvalvular devices can unload the left ventricle, but their use in VSR requires particular caution. Altering left ventricular pressure can change the magnitude and direction of the shunt. The physiological effects therefore need to be understood before deployment.
The intra-aortic balloon pump has historically been used in cardiogenic shock and may reduce afterload and improve coronary perfusion. In mechanical complications, it can sometimes provide modest hemodynamic support, but it does not correct the anatomical defect.
Mechanical support may serve several roles:
Bridge-to-procedure: stabilize the patient until surgical or transcatheter repair can be performed.
Bridge-to-recovery: provide temporary support while ventricular function and systemic organs recover after definitive repair.
Bridge-to-decision: allow time for anatomical clarification and multidisciplinary assessment.
The 2025 AATS consensus specifically highlights mechanical circulatory support as part of contemporary management of AMI complications.
However, MCS should not become an automatic response to every episode of shock. Device-related bleeding, vascular injury, hemolysis, thrombosis, limb ischemia, infection, and neurological complications can substantially increase risk.
The correct question is therefore not “Which device is strongest?” but “Which device produces the most favorable physiology for this specific mechanical lesion?”
17. Revascularization Strategy and the Role of Concomitant CABG
Coronary revascularization remains essential in acute myocardial infarction, but the role of concomitant CABG during emergency repair of a mechanical complication is less straightforward.
Primary PCI is generally preferred for acute coronary reperfusion when feasible. If the culprit vessel has already been treated successfully, the question becomes whether additional surgical bypass will provide meaningful benefit during mechanical complication repair.
CABG may be considered when there is significant residual coronary disease supplying viable myocardium, when PCI is unsuccessful or anatomically unsuitable, or when complete revascularization is expected to improve postoperative ventricular recovery.
However, emergency CABG increases operative time and complexity in a patient who may already be in shock. The potential benefit must therefore be balanced against immediate surgical risk.
The 2021 ACC/AHA/SCAI revascularization guideline notes that emergency surgery may be necessary for mechanical complications of STEMI and that temporary mechanical support may be useful as a bridge. It also highlights the absence of randomized trials establishing the incremental benefit of CABG added to emergency repair of mechanical complications.
The contemporary ESC consensus similarly identifies concomitant coronary revascularization as an area in which practice remains variable and further research is needed.
The practical approach is therefore individualized. Coronary anatomy, viability, residual ischemia, ventricular function, hemodynamic state, operative complexity, and anticipated survival should all influence the decision.
18. Contemporary Surgical Outcomes and Predictors of Mortality
Mechanical complications remain associated with high early mortality despite advances in diagnosis, surgery, PCI, and critical care. The main driver is often not the anatomical defect alone but the degree of cardiogenic shock and secondary organ dysfunction present at the time of definitive treatment.
The Caution multicenter cohort reported 37.4% in-hospital mortality among surgically treated post-AMI mechanical complications. More than half of deaths were attributed to low cardiac output syndrome. Among survivors, overall survival at 1, 5, and 10 years was 54.0%, 48.1%, and 41.0%, respectively.
Importantly, hospital survivors had much better long-term outcomes than the early mortality figures might suggest. This reinforces the importance of successful stabilization through the acute phase.
For free-wall rupture specifically, contemporary surgical series have demonstrated in-hospital mortality around 28.6%, with advanced age, preoperative cardiac arrest, and concomitant VSR predicting poor early outcomes.
VSR outcomes vary according to timing, shock severity, defect anatomy, surgical technique, and patient selection. Early intervention in profoundly unstable patients carries substantial mortality, but delaying intervention in patients with worsening shock can also be dangerous.
Predictors of poor outcome commonly include advanced age, cardiogenic shock, elevated lactate, renal dysfunction, low cardiac output, preoperative cardiac arrest, severe ventricular dysfunction, and multiorgan failure.
These findings support a central contemporary principle: the best predictor of outcome is often the patient’s physiological state at definitive intervention.
This is why early recognition and referral to experienced centers matter. A patient transferred after irreversible multiorgan failure may have dramatically fewer options than the same patient transferred earlier.
19. Postoperative Care, Recurrence, and Long-Term Follow-Up
The postoperative period is not simply a recovery phase; it is a continuation of mechanical-complication management. The repaired myocardium remains fragile, ventricular function may be severely impaired, and residual defects can become clinically important.
Low cardiac output syndrome is a major postoperative threat. The ventricle has suffered an infarction and then undergone major surgery, cardiopulmonary bypass, and abrupt changes in loading conditions. Inotropic support, vasopressors, careful volume management, and mechanical support may be required.
Right ventricular dysfunction is particularly important after VSR repair because the right ventricle may have been exposed to acute volume and pressure overload before closure. Once the shunt is eliminated, loading conditions change abruptly.
Residual VSD should be assessed with echocardiography. Small residual defects may be observed, while clinically important shunts may require additional intervention.
After papillary muscle rupture repair, mitral valve function should be assessed serially. Prosthetic valve function, ventricular recovery, pulmonary pressures, and rhythm should be monitored.
After free-wall rupture repair, imaging is particularly important because recurrent bleeding, pseudoaneurysm, or ventricular wall instability may develop.
The 2026 ESC consensus emphasizes that recurrence can occur even after repair and that close monitoring is required both during hospitalization and after discharge.
Long-term management should also address secondary prevention of coronary disease. Aggressive control of blood pressure, lipids, diabetes, smoking, antiplatelet therapy when indicated, and evidence-based secondary prevention remain essential.
The patient should not be considered “cured” simply because the rupture has been repaired. The underlying myocardial infarction and coronary disease remain major determinants of future cardiovascular risk.
20. Contemporary Heart-Team Algorithm and Future Directions
The contemporary management of AMI mechanical complications can be organized around a simple principle: recognize the anatomical catastrophe, stabilize the physiology, define the anatomy, and achieve definitive repair before irreversible systemic failure develops.
The first step is immediate suspicion when a post-MI patient develops sudden hypotension, pulmonary edema, a new murmur, rising lactate, unexplained right-heart failure, or cardiac arrest.
The second step is immediate echocardiography. The objective is to identify papillary muscle rupture, VSR, free-wall rupture, pseudoaneurysm, or another structural cause.
The third step is simultaneous stabilization. Oxygenation, ventilation, vasoactive support, correction of metabolic abnormalities, and appropriate mechanical support should be considered according to physiology.
The fourth step is urgent activation of the Heart Team, including interventional cardiology, cardiac surgery, advanced imaging, intensive care, anesthesia, and mechanical circulatory support specialists.
The fifth step is lesion-specific definitive treatment:
Papillary muscle rupture: urgent surgical valve replacement or selected repair; transcatheter edge-to-edge therapy may be considered in prohibitive-risk anatomy.
VSR: surgical patch repair remains central, with selected transcatheter closure and mechanical support as alternatives or bridges.
Free-wall rupture: emergency surgical repair is usually required; selected contained pseudoaneurysms may permit planned intervention.
The sixth step is reassessment after definitive treatment for residual defects, ventricular function, pulmonary pressures, organ recovery, and recurrence.
The field is rapidly evolving. The 2026 ESC consensus reflects an important shift toward integrating surgery, transcatheter intervention, advanced imaging, and temporary mechanical circulatory support rather than viewing them as competing approaches.
Future research should focus on prospective multicenter registries, standardized shock phenotyping, patient-specific imaging, improved mechanical support strategies, and better identification of patients who benefit from delayed versus immediate repair.
The rarity of these complications makes randomized trials difficult. Consequently, international collaboration and standardized registries are essential.
The ultimate goal is not simply to reduce operative mortality. It is to shorten the interval between mechanical failure and definitive treatment, prevent irreversible organ injury, and identify the patients in whom surgery or transcatheter intervention can provide durable survival.